News Release

Wex's Clinical Investigator to speak at major conference

Date: Jan17, 2002

TSX Venture Exchange Trading Symbol: WXI
http://www.wextech.ca
E-mail: wex@wextech.ca

International Wex Technologies Inc., the 'Company' is pleased to announce that Dr. Edward M. Sellers has been invited to be a Keynote speaker at the BioITWorld Conference and MedPharma World Conference to be held in Hong Kong during January 29 and 30, 2002.

This premiere event, the first of its kind in Asia, will focus on the convergence of biotechnology, IT and life science. Leading visionaries from life science, biotech development, medical science, as well as IT applications/solutions firms, venture capital/investment firms, researching companies, academics and media will come together to witness how informatics and bioscience have combined to create new landscape for technological advancement and breakthroughs in medical science.

This is of particular interest and potentially very important for the Company as;

Dr. Sellers is our Chief clinical investigator and consultant for both our indications; severe cancer pain and opiate withdrawal treatment and
his topic will use us as a model, whereby a Canadian company using the excellent value for dollar created by utilizing China for product development and the highly reputable Canadian regulatory body to initiate human clinical trials.

Dr. Sellers, M.D., PhD. is President and CEO of Ventana Clinical Research Corporation, Toronto, Ontario, a member of the World Health Organization Expert Advisory Panel on Drug Dependence and a Professor of Pharmacology, Medicine and Psychiatry at the University of Toronto.

In the area of neuro-bioscience, the Company is focusing on the fields of pain management, drug addiction treatment and anaesthesia. The Company is developing products that contain a sodium channel blocking compound and derivatives extracted from natural organic substance using its proprietary manufacturing technology.

For additional information on our products, view the Company website at http://www.wextech.ca or call Howard Milne, V.P. Corporate Communications, at 604-683-8880 or 1-800-722-7549.

Per: Donna Shum, Corporate Secretary

The Canadian Venture Stock Exchange has not reviewed and does not accept responsibility for the adequacy or accuracy of the content of this News Release.